Cargando…

Epigallocatechin-3-Gallate Accelerates Relaxation and Ca(2+) Transient Decay and Desensitizes Myofilaments in Healthy and Mybpc3-Targeted Knock-in Cardiomyopathic Mice

Background: Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac muscle disease with left ventricular hypertrophy, interstitial fibrosis and diastolic dysfunction. Increased myofilament Ca(2+) sensitivity could be the underlying cause of diastolic dysfunction. Epigallocatechin-3-ga...

Descripción completa

Detalles Bibliográficos
Autores principales: Friedrich, Felix W., Flenner, Frederik, Nasib, Mahtab, Eschenhagen, Thomas, Carrier, Lucie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5136558/
https://www.ncbi.nlm.nih.gov/pubmed/27994558
http://dx.doi.org/10.3389/fphys.2016.00607
_version_ 1782471738435567616
author Friedrich, Felix W.
Flenner, Frederik
Nasib, Mahtab
Eschenhagen, Thomas
Carrier, Lucie
author_facet Friedrich, Felix W.
Flenner, Frederik
Nasib, Mahtab
Eschenhagen, Thomas
Carrier, Lucie
author_sort Friedrich, Felix W.
collection PubMed
description Background: Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac muscle disease with left ventricular hypertrophy, interstitial fibrosis and diastolic dysfunction. Increased myofilament Ca(2+) sensitivity could be the underlying cause of diastolic dysfunction. Epigallocatechin-3-gallate (EGCg), a catechin found in green tea, has been reported to decrease myofilament Ca(2+) sensitivity in HCM models with troponin mutations. However, whether this is also the case for HCM-associated thick filament mutations is not known. Therefore, we evaluated whether EGCg affects the behavior of cardiomyocytes and myofilaments of an HCM mouse model carrying a gene mutation in cardiac myosin-binding protein C and exhibiting both increased myofilament Ca(2+) sensitivity and diastolic dysfunction. Methods and Results: Acute effects of EGCg were tested on fractional sarcomere shortening and Ca(2+) transients in intact ventricular myocytes and on force-Ca(2+) relationship of skinned ventricular muscle strips isolated from Mybpc3-targeted knock-in (KI) and wild-type (WT) mice. Fractional sarcomere shortening and Ca(2+) transients were analyzed at 37°C under 1-Hz pacing in the absence or presence of EGCg (1.8 μM). At baseline and in the absence of Fura-2, KI cardiomyocytes displayed lower diastolic sarcomere length, higher fractional sarcomere shortening, longer time to peak shortening and time to 50% relengthening than WT cardiomyocytes. In WT and KI neither diastolic sarcomere length nor fractional sarcomere shortening were influenced by EGCg treatment, but relaxation time was reduced, to a greater extent in KI cells. EGCg shortened time to peak Ca(2+) and Ca(2+) transient decay in Fura-2-loaded WT and KI cardiomyocytes. EGCg did not influence phosphorylation of phospholamban. In skinned cardiac muscle strips, EGCg (30 μM) decreased Ca(2+) sensitivity in both groups. Conclusion: EGCg hastened relaxation and Ca(2+) transient decay to a larger extent in KI than in WT cardiomyocytes. This effect could be partially explained by myofilament Ca(2+) desensitization.
format Online
Article
Text
id pubmed-5136558
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-51365582016-12-19 Epigallocatechin-3-Gallate Accelerates Relaxation and Ca(2+) Transient Decay and Desensitizes Myofilaments in Healthy and Mybpc3-Targeted Knock-in Cardiomyopathic Mice Friedrich, Felix W. Flenner, Frederik Nasib, Mahtab Eschenhagen, Thomas Carrier, Lucie Front Physiol Physiology Background: Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac muscle disease with left ventricular hypertrophy, interstitial fibrosis and diastolic dysfunction. Increased myofilament Ca(2+) sensitivity could be the underlying cause of diastolic dysfunction. Epigallocatechin-3-gallate (EGCg), a catechin found in green tea, has been reported to decrease myofilament Ca(2+) sensitivity in HCM models with troponin mutations. However, whether this is also the case for HCM-associated thick filament mutations is not known. Therefore, we evaluated whether EGCg affects the behavior of cardiomyocytes and myofilaments of an HCM mouse model carrying a gene mutation in cardiac myosin-binding protein C and exhibiting both increased myofilament Ca(2+) sensitivity and diastolic dysfunction. Methods and Results: Acute effects of EGCg were tested on fractional sarcomere shortening and Ca(2+) transients in intact ventricular myocytes and on force-Ca(2+) relationship of skinned ventricular muscle strips isolated from Mybpc3-targeted knock-in (KI) and wild-type (WT) mice. Fractional sarcomere shortening and Ca(2+) transients were analyzed at 37°C under 1-Hz pacing in the absence or presence of EGCg (1.8 μM). At baseline and in the absence of Fura-2, KI cardiomyocytes displayed lower diastolic sarcomere length, higher fractional sarcomere shortening, longer time to peak shortening and time to 50% relengthening than WT cardiomyocytes. In WT and KI neither diastolic sarcomere length nor fractional sarcomere shortening were influenced by EGCg treatment, but relaxation time was reduced, to a greater extent in KI cells. EGCg shortened time to peak Ca(2+) and Ca(2+) transient decay in Fura-2-loaded WT and KI cardiomyocytes. EGCg did not influence phosphorylation of phospholamban. In skinned cardiac muscle strips, EGCg (30 μM) decreased Ca(2+) sensitivity in both groups. Conclusion: EGCg hastened relaxation and Ca(2+) transient decay to a larger extent in KI than in WT cardiomyocytes. This effect could be partially explained by myofilament Ca(2+) desensitization. Frontiers Media S.A. 2016-12-05 /pmc/articles/PMC5136558/ /pubmed/27994558 http://dx.doi.org/10.3389/fphys.2016.00607 Text en Copyright © 2016 Friedrich, Flenner, Nasib, Eschenhagen and Carrier. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Physiology
Friedrich, Felix W.
Flenner, Frederik
Nasib, Mahtab
Eschenhagen, Thomas
Carrier, Lucie
Epigallocatechin-3-Gallate Accelerates Relaxation and Ca(2+) Transient Decay and Desensitizes Myofilaments in Healthy and Mybpc3-Targeted Knock-in Cardiomyopathic Mice
title Epigallocatechin-3-Gallate Accelerates Relaxation and Ca(2+) Transient Decay and Desensitizes Myofilaments in Healthy and Mybpc3-Targeted Knock-in Cardiomyopathic Mice
title_full Epigallocatechin-3-Gallate Accelerates Relaxation and Ca(2+) Transient Decay and Desensitizes Myofilaments in Healthy and Mybpc3-Targeted Knock-in Cardiomyopathic Mice
title_fullStr Epigallocatechin-3-Gallate Accelerates Relaxation and Ca(2+) Transient Decay and Desensitizes Myofilaments in Healthy and Mybpc3-Targeted Knock-in Cardiomyopathic Mice
title_full_unstemmed Epigallocatechin-3-Gallate Accelerates Relaxation and Ca(2+) Transient Decay and Desensitizes Myofilaments in Healthy and Mybpc3-Targeted Knock-in Cardiomyopathic Mice
title_short Epigallocatechin-3-Gallate Accelerates Relaxation and Ca(2+) Transient Decay and Desensitizes Myofilaments in Healthy and Mybpc3-Targeted Knock-in Cardiomyopathic Mice
title_sort epigallocatechin-3-gallate accelerates relaxation and ca(2+) transient decay and desensitizes myofilaments in healthy and mybpc3-targeted knock-in cardiomyopathic mice
topic Physiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5136558/
https://www.ncbi.nlm.nih.gov/pubmed/27994558
http://dx.doi.org/10.3389/fphys.2016.00607
work_keys_str_mv AT friedrichfelixw epigallocatechin3gallateacceleratesrelaxationandca2transientdecayanddesensitizesmyofilamentsinhealthyandmybpc3targetedknockincardiomyopathicmice
AT flennerfrederik epigallocatechin3gallateacceleratesrelaxationandca2transientdecayanddesensitizesmyofilamentsinhealthyandmybpc3targetedknockincardiomyopathicmice
AT nasibmahtab epigallocatechin3gallateacceleratesrelaxationandca2transientdecayanddesensitizesmyofilamentsinhealthyandmybpc3targetedknockincardiomyopathicmice
AT eschenhagenthomas epigallocatechin3gallateacceleratesrelaxationandca2transientdecayanddesensitizesmyofilamentsinhealthyandmybpc3targetedknockincardiomyopathicmice
AT carrierlucie epigallocatechin3gallateacceleratesrelaxationandca2transientdecayanddesensitizesmyofilamentsinhealthyandmybpc3targetedknockincardiomyopathicmice